Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well that doesn’t answer the question at all that why haven’t they answered this question still . No patients are being enrolled , data has long been published and locked . Trial has officially ended . And above has been true for few years now . So I haven’t seen a single logical reason in your post to explain above .
It is two year old post . Data is already published ?
Hmm
DCVax is own and made by private companies . The revenue will go to those companies and not to Britain except for taxes that any other business pays . It’s unnecessary pump
How big was that trade ? If it was few hundred or few thousand shares , it is a fluke and incosequential
I guess no logical answers
Well if it was about trial integrity , they had ample time to disclose that after the trial was over . It has been years since the trial has been over , data locked and results published . And they know that shareholders had been asking for the reason and shorters have used the silence against the company . So it defies the logic that if trial integrity was the reason , they didn’t still disclose it to put the questions to rest .
And how many has she bought in last 10 years
Well if they are going to use all the loan amount for the stated purposes then where will they find the money to pay the existing loans due by end of the year I think
If what all has been speculated here over last year is somewhat true :
- MHRA is already familiar with DCVax and has been working with NWBO all these years
- MHRA is inclined to do faster approvals for meds for critical diseases
- there is political support
Then I would assume that given the volume of the application , they likely had been requesting multiple informations which have sequentially been provided by company as the requests kept coming in . I don’t think for such a complex application , that kind of request or exchange will be limited to one point in time with one chance to reply and one chance to review the answer .
Well whatever the source , seems like a fluke because bid - ask currently in pre market is in .40s
Chance to make significant money in short duration can change narrative overnight .
Yep it happens on OTC often , that those trades are balanced after hours , but the price difference is not more than 5-10% at the most that I have seen . But Fidelity site says that one can trade OTC after hours . So not sure what those trades posted on Stocktwits represent
We can only hope it is time
I was also under impression that OTC can’t be traded after hours
Looks like fidelity says yes
https://www.fidelity.com/viewpoints/active-investor/extended-hours-trading
3-4 months will mean few months to most people . So esp while talking about NWBO , several likely means much more than that
Let’s see if SP hopefully starts going up
Sure 50 cents have been hugely relevant in doubling of shares since datalock when no active trial was ongoing. To think otherwise is willfully ignoring the facts/events which have happened in black and white .
Well let’s see if that article comes out before approval , how does it affect the SP. I am quite sure it won’t make any difference for more than 1-2 days if that .
Anything academic is of no interest to market this late in the game . Market needs to see the Money , plan to monetize , BO , JV etc .
Ohh can it
But somehow LP is still a genius … interesting
Zero chance they gave up
Oh and I forgot about the huge institutional holdings because of contacts
Yep we have seen that by doubling the share count since data lock during which time no active trial was going on . That certainly was a very innovative way of financing .
Only massive volume day after day consistently will overwhelm them. Or major institutional buying which likely will require uplifting.
See what happened Trump media stock after the company blamed manipulation and naked shorting - same players - citadel etc
All credible sources show new GBM cases between 2200-3000 in Uk . Yet some here keep throwing 12k without providing any credible source . Even if you include rGBM , it can’t come anywhere close to 12K
That’s exactly the point - 20 years and no approval yet . I doubt that is considered an epitome of good management .
Common they always have big booth at ASCO and sometimes even tote bags
I think most long term investors will take it and get out of this rut
And what does this have to do with applying for DcVax and Poly combo approval ??? Please help us out
With all the delays over more than a decade why would they muddy their application by adding another factor at the last minute with data that doesn’t belong to a trial linked to approval . It makes no sense unless they set up some definitive understanding/ deal with MHRA. And why would they not include it in the PR as changing the application last minute for what to apply for would be an important event if not material .
Sure they can be
The problem is the breadcrumbs have been connected here to pretty much every major BP on this board . When all outcomes are possible , then there is no specific hypothesis .
Completely agree
If Hiltonol is an approved drug , and NWBO doesn’t own that company , why would they need to or can apply for the approval to use that drug . It’s upto oncologist to use any combination of approved drugs ??
It’s beyond speculation . PT clearly stated in black and white what they applied for
Good
And same Delaware court decided against Elon Musk as well I believe
Exactly
There has been no action/hiring to show that they are getting ready for global launch in next year .
Sure
Then everyone was so sure that Duffy came from Merck to acquire NWBO . Breadcrumbs never end
According to these posters GBM only affects millionaires